home / stock / idxg / idxg quote
Last: | $3.92 |
---|---|
Change Percent: | 0.51% |
Open: | $3.92 |
Close: | $3.92 |
High: | $4.18 |
Low: | $3.851 |
Volume: | 115,875 |
Last Trade Date Time: | 02/24/2021 04:55:40 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.92 | $3.92 | $3.92 | $4.18 | $3.851 | 115,875 | 02-24-2021 |
$3.9 | $4.09 | $3.9 | $4.1527 | $3.72 | 179,169 | 02-23-2021 |
$4.23 | $4.3 | $4.23 | $4.3199 | $4.09 | 103,576 | 02-22-2021 |
$4.3 | $3.99 | $4.3 | $4.46 | $3.99 | 200,920 | 02-19-2021 |
$4.06 | $4.38 | $4.06 | $4.424 | $3.98 | 378,540 | 02-18-2021 |
$4.44 | $3.98 | $4.44 | $4.8 | $3.76 | 1,263,335 | 02-17-2021 |
$5.84 | $5.76 | $5.84 | $5.97 | $5.61 | 80,230 | 02-16-2021 |
$5.77 | $5.62 | $5.77 | $5.78 | $5.5001 | 89,676 | 02-15-2021 |
$5.77 | $5.62 | $5.77 | $5.78 | $5.5001 | 89,655 | 02-12-2021 |
$5.61 | $5.43 | $5.61 | $5.9899 | $5.39 | 226,476 | 02-11-2021 |
$5.44 | $5.86 | $5.44 | $5.9 | $5.29 | 165,029 | 02-10-2021 |
$5.7 | $5.3 | $5.7 | $5.79 | $5.19 | 294,412 | 02-09-2021 |
$5.29 | $4.95 | $5.29 | $5.47 | $4.93 | 258,512 | 02-08-2021 |
$4.85 | $5 | $4.85 | $5.01 | $4.6 | 177,275 | 02-05-2021 |
$5.06 | $5.02 | $5.06 | $5.4726 | $5.02 | 266,808 | 02-04-2021 |
$5.05 | $4.3 | $5.05 | $5.06 | $4.3 | 374,666 | 02-03-2021 |
$4.22 | $4.35 | $4.22 | $4.55 | $4.15 | 289,537 | 02-02-2021 |
$4.34 | $4.5 | $4.34 | $4.6 | $4.06 | 217,034 | 02-01-2021 |
$4.02 | $4.21 | $4.02 | $4.3399 | $3.9901 | 134,501 | 01-29-2021 |
$4.24 | $5.13 | $4.24 | $5.9 | $3.75 | 1,889,380 | 01-28-2021 |
News, Short Squeeze, Breakout and More Instantly...
Interpace Biosciences Inc. Company Name:
IDXG Stock Symbol:
NASDAQ Market:
Interpace Biosciences Inc. Website:
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® (OTCQX: IDXG), is proud to announce that new data demonstrating the application of advanced sequencing technologies in pancreatic cancer was published as an e-ab...
PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update. First quarter Net ...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...